TP53 somatic evolution in healthy fallopian tube across the full spectrum of human lifespan

被引:0
|
作者
Risques, Rosana
Coombes, Coohleen
Fredrickson, Jeanne
Parker, Elizabeth U.
Kohrn, Brendan
Latorre-Esteves, Elena S.
Hazard, Emma
Milan, Eden M.
Katz, Ronit
机构
关键词
D O I
10.1158/1538-7445.AGCA22-PR005
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PR005
引用
收藏
页数:2
相关论文
共 31 条
  • [21] Human Fallopian Tube-Derived Organoids with TP53 and RAD51D Mutations Recapitulate an Early Stage High-Grade Serous Ovarian Cancer Phenotype In Vitro
    Dai, Yilin
    Xu, Jing
    Gong, Xiaofeng
    Wei, Jinsong
    Gao, Yi
    Chai, Ranran
    Lu, Chong
    Zhao, Bing
    Kang, Yu
    Isachenko, Vladimir
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (02)
  • [22] Prevalence and spectrum of AKT1, PIK3CA, PTEN and TP53 somatic mutations in Chinese breast cancer patients
    Li, Guoli
    Guo, Xinwu
    Chen, Ming
    Tang, Lili
    Jiang, Hui
    Day, Julia X.
    Xie, Yueliang
    Peng, Limin
    Xu, Xunxun
    Li, Jinliang
    Wang, Shouman
    Xiao, Zhi
    Dai, Lizhong
    Wang, Jun
    PLOS ONE, 2018, 13 (09):
  • [23] Cytoplasmic Pattern Aberrant p53 Immunohistochemical Expression in STIC and Fallopian Tube High Grade Serous Carcinoma with TP53 Mutations in the Nuclear Localization Domain: A Potential Diagnostic Pitfall
    Miller, Christine
    Devine, Walter
    Rabban, Joseph
    LABORATORY INVESTIGATION, 2024, 104 (03) : S1211 - S1211
  • [24] Comparison of TP53 Mutations Across the Spectrum of Myeloid Malignancies Suggests Divergent Functional Roles in Initiation of Myelodysplasia and Progression to Acute Leukemia
    Jambhekar, Ashwini
    Ackerman, Emily
    Lahav, Galit
    Lovitch, Scott
    LABORATORY INVESTIGATION, 2023, 103 (03) : S1160 - S1162
  • [25] Ultra-Sensitive TP53 Sequencing for Cancer Detection Reveals Progressive Clonal Selection in Normal Tissue over a Century of Human Lifespan
    Salk, Jesse J.
    Loubet-Senear, Kaitlyn
    Maritschnegg, Elisabeth
    Valentine, Charles C.
    Williams, Lindsey N.
    Higgins, Jacob E.
    Horvat, Reinhard
    Vanderstichele, Adriaan
    Nachmanson, Daniela
    Baker, Kathryn T.
    Emond, Mary J.
    Loter, Emily
    Tretiakova, Maria
    Soussi, Thierry
    Loeb, Lawrence A.
    Zeillinger, Robert
    Speiser, Paul
    Risques, Rosa Ana
    CELL REPORTS, 2019, 28 (01): : 132 - +
  • [26] ROS in ovulatory follicular fluid exert de novo mutagenic activities through activation-induced cytidine deaminase acting on the TP53 gene in the fallopian tube epithelial cell
    Chu, Tang-Yuan
    Subramani, Sanchana
    Huang, Hsuan-Shun
    CANCER RESEARCH, 2024, 84 (05)
  • [27] Molecular spectrum of KRAS, NRAS, BRAF, PIK3CA, TP53, and APC somatic gene mutations in Arab patients with colorectal cancer: determination of frequency and distribution pattern
    Al-Shamsi, Humaid O.
    Jones, Jeremy
    Fahmawi, Yazan
    Dahbour, Ibrahim
    Tabash, Aziz
    Abdel-Wahab, Reham
    Abousamra, Ahmed O. S.
    Shaw, Kenna R.
    Xiao, Lianchun
    Hassan, Manal M.
    Kipp, Benjamin R.
    Kopetz, Scott
    Soliman, Amr S.
    McWilliams, Robert R.
    Wolff, Robert A.
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2016, 7 (06) : 882 - +
  • [28] TP53 somatic evolution in cervical liquid-based cytology and blood from individuals with and without ovarian cancer and BRCA1 or BRCA2 germline mutations
    Ghezelayagh, Talayeh S.
    Kohrn, Brendan F.
    Fredrickson, Jeanne
    Krimmel-Morrison, Jeffrey D.
    Latorre-Esteves, Elena
    Tee, Xin-Ray
    Radke, Marc R.
    Manhardt, Enna
    Norquist, Barbara M.
    Katz, Ronit
    Swisher, Elizabeth M.
    Risques, Rosa Ana
    ONCOGENE, 2024, 43 (31) : 2421 - 2430
  • [29] The PPARγ Agonist Efatutazone Increases the Spectrum of Well-Differentiated Mammary Cancer Subtypes Initiated by Loss of Full-Length BRCA1 in Association with TP53 Haploinsufficiency
    Nakles, Rebecca E.
    Kallakury, Bhaskar V. S.
    Furth, Priscilla A.
    AMERICAN JOURNAL OF PATHOLOGY, 2013, 182 (06): : 1976 - 1985
  • [30] Initiation of human astrocytoma by clonal evolution of cells with progressive loss of p53 functions in a patient with a 283H TP53 germ-line mutation:: Evidence for a precursor lesion
    Fulci, G
    Ishii, N
    Maurici, D
    Gernert, KM
    Hainaut, P
    Kaur, B
    Van Meir, EG
    CANCER RESEARCH, 2002, 62 (10) : 2897 - 2905